• Resources
  • Blog
  • Journalists
  • Log In
  • Sign Up
  • Data Privacy
  • Send a Release
Cision PR Newswire: news distribution, targeting and monitoring home
  • News
  • Products
    • Overview
    • Distribution by PR Newswire
    • Cision Communications Cloud®
    • Cision IR
    • All Products
  • Contact
    • General Inquiries
    • Request a Demo
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices

 

When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Overview
  • Distribution by PR Newswire
  • Cision Communications Cloud®
  • Cision IR
  • All Products
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • Overview
  • Distribution by PR Newswire
  • Cision Communications Cloud®
  • Cision IR
  • All Products
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR

Reportlinker Adds AIDS-related Kaposi's Sarcoma (ARKS) Therapeutics - Pipeline Assessment and Market Forecasts to 2017


News provided by

Reportlinker

Jun 09, 2011, 06:55 ET

Share this article

Share this article


NEW YORK, June 9, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

AIDS-related Kaposi's Sarcoma (ARKS) Therapeutics - Pipeline Assessment and Market Forecasts to 2017

http://www.reportlinker.com/p0548323/AIDS-related-Kaposi's-Sarcoma-ARKS-Therapeutics---Pipeline-Assessment-and-Market-Forecasts-to-2017.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology

AIDS-related Kaposi's Sarcoma (ARKS) Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Summary

GlobalData, the industry analysis specialist, has released its new report, "AIDS-related Kaposi's Sarcoma (ARKS) Therapeutics - Pipeline Assessment and Market Forecasts to 2017". The report is an essential source of information and analysis on the global AIDS Related Kaposi's Sarcoma Therapeutics market. The report identifies the key trends shaping and driving the global AIDS Related Kaposi's Sarcoma Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global AIDS Related Kaposi's Sarcoma Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

The report provides information on the key drivers and challenges of the AIDS Related Kaposi's Sarcoma Therapeutics market. Its scope includes -

- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) AIDS Related Kaposi's Sarcoma Therapeutics market revenues data from 2005 to 2009, forecast for eight years to 2017.

- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.

- Analysis of the current and future competition in the seven key countries AIDS Related Kaposi's Sarcoma Therapeutics market.

- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.

- Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the AIDS Related Kaposi's Sarcoma Therapeutics therapeutics market.

- Analysis of key recent licensing and partnership agreements in AIDS Related Kaposi's Sarcoma Therapeutics market

Reasons to buy

The report will enhance your decision making capability. It will allow you to -

- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.

- Develop business strategies by understanding the trends shaping and driving the global AIDS Related Kaposi's Sarcoma Therapeutics market.

- Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global AIDS Related Kaposi's Sarcoma Therapeutics market in future.

- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

- What's the next big thing in the global AIDS Related Kaposi's Sarcoma Therapeutics market landscape? – Identify, understand and capitalize.

1 Table of contents

1 Table of contents 2

1.1 List of Tables 4

1.2 List of Figures 5

2 AIDS-related Kaposi's Sarcoma (ARKS) Therapeutics: Introduction 6

2.1 Overview 6

2.2 Epidemiology 6

2.3 Symptoms 7

2.4 Pathogenesis of ARKS 8

2.5 Staging of ARKS 9

2.6 Diagnosis of ARKS 9

2.7 Treatment of ARKS 9

2.7.1 Local Treatment 10

2.7.2 Cytotoxic Chemotherapy 10

2.7.3 Molecular Targeted Therapy 10

2.7.4 HAART (Highly Active Antiretroviral Treatment) 10

2.8 GlobalData Pipeline Report Guidance 11

3 AIDS-related Kaposi's Sarcoma (ARKS) Therapeutics: Market Characterization 12

3.1 ARKS Therapeutics Market Size (2005–2010) – Global 12

3.2 ARKS Therapeutics Market Forecast (2010–2017) – Global 13

3.3 ARKS Therapeutics Market Size (2005–2010) – The US 14

3.4 ARKS Therapeutics Market Forecast (2010–2017) – The US 15

3.5 ARKS Therapeutics Market Size (2005–2010) – France 16

3.6 ARKS Therapeutics Market Forecast (2010–2017) – France 17

3.7 ARKS Therapeutics Market Size (2005–2010) – Germany 18

3.8 ARKS Therapeutics Market Forecast (2010–2017) – Germany 19

3.9 ARKS Therapeutics Market Size (2005–2010) – Italy 20

3.10 ARKS Therapeutics Market Forecast (2010–2017) – Italy 21

3.11 ARKS Therapeutics Market Size (2005–2010) – Spain 22

3.12 ARKS Therapeutics Market Forecast (2010–2017) – Spain 23

3.13 ARKS Therapeutics Market Size (2005–2010) – The UK 24

3.14 ARKS Therapeutics Market Forecast (2010–2017) – The UK 25

3.15 ARKS Therapeutics Market Size (2005–2010) – Japan 26

3.16 ARKS Therapeutics Market Forecast (2010–2017) – Japan 27

3.17 Drivers and Barriers for the ARKS Therapeutics Market 28

3.17.1 Barriers for the ARKS Therapeutics Market 28

3.18 Opportunity and Unmet Need Analysis 28

3.19 Key Takeaway 29

4 AIDS-related Kaposi's Sarcoma (ARKS) Therapeutics: Competitive Assessment 30

4.1 Overview 30

4.2 Strategic Competitor Assessment 30

4.3 Product Profiles for Major Marketed Products in the ARKS Therapeutics Market 31

4.3.1 Doxil 31

4.3.2 Daunorubicin 33

4.3.3 Paclitaxel 34

4.3.4 Panretin (alitretinoin) 35

4.4 Key Takeaway 36

5 AIDS-related Kaposi's Sarcoma (ARKS) Therapeutics: Pipeline Assessment 37

5.1 Overview 37

5.2 Strategic Pipeline Assessment 37

5.3 ARKS Therapeutics Pipeline – Pipeline by Phases of Development 37

5.3.1 ARKS Therapeutics – Phase II Pipeline 38

5.3.2 ARKS Therapeutics – Phase I Pipeline 38

5.3.3 ARKS Therapeutics – Preclinical Pipeline 38

5.3.4 Technology Trends Analytic Framework 39

5.4 ARKS Therapeutics – Pipeline by Mechanism of Action 41

5.5 Key Takeaway 41

6 AIDS-related Kaposi's Sarcoma (ARKS) Therapeutics: Clinical Trials Mapping 42

6.1 Clinical Trials by Country (US, EU5 and Japan) 42

6.2 Clinical Trials by Phase 43

6.3 Clinical Trials by Trial Status 44

6.4 Prominent Sponsors 45

6.5 Top Companies Participating in ARKS Therapeutics Clinical Trials 47

7 AIDS-related Kaposi's Sarcoma (ARKS) Therapeutics: Strategic Assessment 48

7.1 ARKS Therapeutics: Implications for Future Market Competition 48

8 AIDS-related Kaposi's Sarcoma (ARKS) Therapeutics: Future Players 49

8.1 Introduction 49

8.2 Company Profiles 50

8.2.1 PTC Therapeutics, Inc. 50

8.2.2 Aphios Corporation 51

9 AIDS-related Kaposi's Sarcoma (ARKS) Therapeutics: Licensing and Partnership Deals 53

10 AIDS-related Kaposi's Sarcoma (ARKS) Therapeutics: Appendix 54

10.1 Market Definitions 54

10.2 Abbreviations 54

10.3 Research Methodology 55

10.3.1 Coverage 55

10.3.2 Secondary Research 55

10.3.3 Forecasting 56

10.3.4 Primary Research 59

10.3.5 Expert Panel Validation 59

10.4 Contact Us 59

10.5 Disclaimer 59

10.6 Bibliography 60

1.1

List of Tables

Table 1: Prevalence of Kaposi's Sarcoma in HIV Patients, Top Seven Markets, 2010 6

Table 2: AIDS Clinical Trials Group Staging Classification for ARKS, 2011 9

Table 3: ARKS Therapeutics Market, Global, Revenue ($m), 2005–2010 12

Table 4: ARKS Therapeutics Market, Global, Forecast ($m), 2010–2017 13

Table 5: ARKS Therapeutics Market, The US, Revenue ($m), 2005–2010 14

Table 6: ARKS Therapeutics Market, The US, Forecast ($m), 2010–2017 15

Table 7: ARKS Therapeutics Market, France, Revenue ($'000), 2005–2010 16

Table 8: ARKS Therapeutics Market, France, Forecast ($'000), 2010–2017 17

Table 9: ARKS Therapeutics Market, Germany, Revenue ($'000), 2005–2010 18

Table 10: ARKS Therapeutics Market, Germany, Forecast ($'000), 2010–2017 19

Table 11: ARKS Therapeutics Market, Italy, Revenue ($'000), 2005–2010 20

Table 12: ARKS Therapeutics Market, Italy, Forecast ($'000), 2010–2017 21

Table 13: ARKS Therapeutics Market, Spain, Revenue ($'000), 2005–2010 22

Table 14: ARKS Therapeutics Market, Spain, Forecast ($'000), 2010–2017 23

Table 15: ARKS Therapeutics Market, The UK, Revenue ($'000), 2005–2010 24

Table 16: ARKS Therapeutics Market, The UK, Forecast ($'000), 2010–2017 25

Table 17: ARKS Therapeutics Market, Japan, Revenue ($'000), 2005–2010 26

Table 18: ARKS Therapeutics Market, Japan, Forecast ($'000), 2010–2017 27

Table 19: Response in Patients with Refractory AIDS-related Kaposi's Sarcoma 32

Table 20: Panretin Clinical Study Response 36

Table 21: ARKS Therapeutics – Phase II Pipeline, 2011 38

Table 22: ARKS Therapeutics – Phase I Pipeline, 2011 38

Table 23: ARKS Therapeutics – Preclinical Pipeline, 2011 38

Table 24: ARKS Therapeutics – Clinical Trials by Country, 2011 42

Table 25: ARKS Therapeutics - Clinical Trials by Phase, 2011 43

Table 26: ARKS Therapeutics - Clinical Trials by Status, 2011 44

Table 27: ARKS Therapeutics - Prominent Sponsors, 2011 46

Table 28: ARKS Therapeutics – Companies and Institutions Participating in Clinical Trials, 2011 47

Table 29: PTC Therapeutics, Pipeline Products, 2011 50

Table 30: PTC Therapeutics, Deals, 2009-2011 51

Table 31: Aphios Corporation, Pipeline Products, 2011 52

Table 32: Aphios Corporation, Deals, 2009-2011 52

Table 33: ARKS Therapeutics, Global, Deals 53

1.2

List of Figures

Figure 1: Etiology of KS 8

Figure 2: ARKS Therapeutics Market, Global, Revenue ($m), 2005–2010 12

Figure 3: ARKS Therapeutics Market, Global, Forecast ($m), 2010–2017 13

Figure 4: ARKS Therapeutics Market, The US, Revenue ($m), 2005–2010 14

Figure 5: ARKS Therapeutics Market, The US, Forecast ($m), 2010–2017 15

Figure 6: ARKS Therapeutics Market, France, Revenue ($'000), 2005–2010 16

Figure 7: ARKS Therapeutics Market, France, Forecast ($'000), 2010–2017 17

Figure 8: ARKS Therapeutics Market, Germany, Revenue ($'000), 2005–2010 18

Figure 9: ARKS Therapeutics Market, Germany, Forecast ($'000), 2010–2017 19

Figure 10: ARKS Therapeutics Market, Italy, Revenue ($'000), 2005–2010 20

Figure 11: ARKS Therapeutics Market, Italy, Forecast ($'000), 2010–2017 21

Figure 12: ARKS Therapeutics Market, Spain, Revenue ($'000), 2005–2010 22

Figure 13: ARKS Therapeutics Market, Spain, Forecast ($'000), 2010–2017 23

Figure 14: ARKS Therapeutics Market, The UK, Revenue ($'000), 2005–2010 24

Figure 15: ARKS Therapeutics Market, The UK, Forecast ($'000), 2010–2017 25

Figure 16: ARKS Therapeutics Market, Japan, Revenue ($'000), 2005–2010 26

Figure 17: ARKS Therapeutics Market, Japan, Forecast ($'000), 2010–2017 27

Figure 18: ARKS Therapeutics Market, Drivers and Barriers, 2010 28

Figure 19: Opportunity and Unmet Need in the ARKS Therapeutics Market, 2010 29

Figure 20: ARKS Therapeutics – Strategic Competitor Assessment, 2010 30

Figure 21: ARKS Therapeutics – Pipeline by Phase of Development, (%), 2010 37

Figure 22: ARKS Therapeutics – Technology Trends Analytic Framework, 2011 39

Figure 23: ARKS Therapeutics – Technology Trends Analytic Framework – Description, 2011 40

Figure 24: ARKS Therapeutics – Pipeline by Mechanism of Action, (%), 2011 41

Figure 25: ARKS Therapeutics – Clinical Trials by Country, 2011 42

Figure 26: ARKS Therapeutics – Clinical Trials by Phase, (%), 2011 43

Figure 27: ARKS Therapeutics - Clinical Trials by Status, (%), 2011 44

Figure 28: ARKS Therapeutics - Overall Sponsors, (%), 2011 45

Figure 29: ARKS Therapeutics - Sponsors, (%), 2011 46

Figure 30: ARKS Therapeutics - Top Companies Participating in Therapeutics Clinical Trials, 2011 47

Figure 31: Implications for Future Market Competition in the ARKS Therapeutics Market, 2010 48

Figure 32: ARKS Therapeutics – Pipeline by Company, 2010 49

Figure 33: GlobalData Market Forecasting Model 58

Companies Mentioned

PTC Therapeutics, Inc.

Aphios Corporation

To order this report:

Pathology Industry: AIDS-related Kaposi's Sarcoma (ARKS) Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Pathology Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker

Modal title

Contact Cision

  • Cision Distribution 888-776-0942
    from 8 AM - 9 PM ET

  • Chat with an Expert
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • Cision Communication Cloud®
  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • For Small Business
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • COVID-19 Resources
  • Accessibility Statement
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom

My Services

  • All New Releases
  • Online Member Center
  • ProfNet

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2022 Cision US Inc.